Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study

Standard

Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study. / Metzner, Andreas; Straube, Florian; Tilz, Roland R; Kuniss, Malte; Noelker, Georg; Tebbenjohanns, Juergen; Andresen, Dietrich; Wieneke, Heinrich; Stellbrink, Christoph; Franke, Jennifer; Dorwarth, Uwe; Carion, Phuong Lien; Holbrook, Reece; Hochadel, Matthias; Senges, Jochen; Hoffmann, Ellen; Kuck, Karl-Heinz; FREEZE Cohort Study Investigators .

in: BMC CARDIOVASC DISOR, Jahrgang 23, Nr. 1, 09.01.2023, S. 8.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Metzner, A, Straube, F, Tilz, RR, Kuniss, M, Noelker, G, Tebbenjohanns, J, Andresen, D, Wieneke, H, Stellbrink, C, Franke, J, Dorwarth, U, Carion, PL, Holbrook, R, Hochadel, M, Senges, J, Hoffmann, E, Kuck, K-H & FREEZE Cohort Study Investigators 2023, 'Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study', BMC CARDIOVASC DISOR, Jg. 23, Nr. 1, S. 8. https://doi.org/10.1186/s12872-022-03015-8

APA

Metzner, A., Straube, F., Tilz, R. R., Kuniss, M., Noelker, G., Tebbenjohanns, J., Andresen, D., Wieneke, H., Stellbrink, C., Franke, J., Dorwarth, U., Carion, P. L., Holbrook, R., Hochadel, M., Senges, J., Hoffmann, E., Kuck, K-H., & FREEZE Cohort Study Investigators (2023). Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study. BMC CARDIOVASC DISOR, 23(1), 8. https://doi.org/10.1186/s12872-022-03015-8

Vancouver

Bibtex

@article{44221f42acc94d93862321e87ccc9fad,
title = "Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study",
abstract = "BACKGROUND: Pulmonary vein isolation (PVI) is recommended to treat paroxysmal and persistent atrial fibrillation (AF). This analysis aimed to assess the hospital efficiency of single-shot cryoballoon ablation (CBA) and point-by-point radiofrequency ablation (RFA).METHODS: The discrete event simulation used PVI procedure times from the FREEZE Cohort study to establish the electrophysiology (EP) lab occupancy time. 1000 EP lab days were simulated according to an illustrative German hospital, including 3 PVI cases per day using CBA at one site and RFA at the other.RESULTS: The analysis included 1560 CBA patients and 1344 RFA patients from the FREEZE Cohort. Some baseline patients' characteristics were different between groups (age, AF type, and some concomitant diseases), without being statistically associated to ablation procedure time. Mean procedure time was 122.2 ± 39.4 min for CBA and 160.3 ± 53.5 min for RFA (p < 0.0001). RFA was associated with a more than five-fold increase of cumulative overtime compared to CBA over the simulated period (1285 h with RFA and 253 h with CBA). 70.7% of RFA lab days included overtime versus 25.7% for CBA. CBA was associated with more days with an additional hour at the end of the EP lab shift compared to RFA (47.8% vs 11.5% days with one hour left, respectively).CONCLUSION: CBA is faster and more predictable than point-by-point RFA, and enables improvements in EP lab efficiency, including: fewer cumulative overtime hours, more days where overtime is avoided and more days with remaining time for the staff or for any EP lab usage. Clinical trial registration NCT01360008 (first registration 25/05/2011).",
keywords = "Humans, Cohort Studies, Cryosurgery/adverse effects, Atrial Fibrillation/diagnosis, Catheter Ablation/adverse effects, Pulmonary Veins/surgery, Electrophysiology, Treatment Outcome, Recurrence",
author = "Andreas Metzner and Florian Straube and Tilz, {Roland R} and Malte Kuniss and Georg Noelker and Juergen Tebbenjohanns and Dietrich Andresen and Heinrich Wieneke and Christoph Stellbrink and Jennifer Franke and Uwe Dorwarth and Carion, {Phuong Lien} and Reece Holbrook and Matthias Hochadel and Jochen Senges and Ellen Hoffmann and Karl-Heinz Kuck and {FREEZE Cohort Study Investigators}",
note = "{\textcopyright} 2023. The Author(s).",
year = "2023",
month = jan,
day = "9",
doi = "10.1186/s12872-022-03015-8",
language = "English",
volume = "23",
pages = "8",
journal = "BMC CARDIOVASC DISOR",
issn = "1471-2261",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study

AU - Metzner, Andreas

AU - Straube, Florian

AU - Tilz, Roland R

AU - Kuniss, Malte

AU - Noelker, Georg

AU - Tebbenjohanns, Juergen

AU - Andresen, Dietrich

AU - Wieneke, Heinrich

AU - Stellbrink, Christoph

AU - Franke, Jennifer

AU - Dorwarth, Uwe

AU - Carion, Phuong Lien

AU - Holbrook, Reece

AU - Hochadel, Matthias

AU - Senges, Jochen

AU - Hoffmann, Ellen

AU - Kuck, Karl-Heinz

AU - FREEZE Cohort Study Investigators

N1 - © 2023. The Author(s).

PY - 2023/1/9

Y1 - 2023/1/9

N2 - BACKGROUND: Pulmonary vein isolation (PVI) is recommended to treat paroxysmal and persistent atrial fibrillation (AF). This analysis aimed to assess the hospital efficiency of single-shot cryoballoon ablation (CBA) and point-by-point radiofrequency ablation (RFA).METHODS: The discrete event simulation used PVI procedure times from the FREEZE Cohort study to establish the electrophysiology (EP) lab occupancy time. 1000 EP lab days were simulated according to an illustrative German hospital, including 3 PVI cases per day using CBA at one site and RFA at the other.RESULTS: The analysis included 1560 CBA patients and 1344 RFA patients from the FREEZE Cohort. Some baseline patients' characteristics were different between groups (age, AF type, and some concomitant diseases), without being statistically associated to ablation procedure time. Mean procedure time was 122.2 ± 39.4 min for CBA and 160.3 ± 53.5 min for RFA (p < 0.0001). RFA was associated with a more than five-fold increase of cumulative overtime compared to CBA over the simulated period (1285 h with RFA and 253 h with CBA). 70.7% of RFA lab days included overtime versus 25.7% for CBA. CBA was associated with more days with an additional hour at the end of the EP lab shift compared to RFA (47.8% vs 11.5% days with one hour left, respectively).CONCLUSION: CBA is faster and more predictable than point-by-point RFA, and enables improvements in EP lab efficiency, including: fewer cumulative overtime hours, more days where overtime is avoided and more days with remaining time for the staff or for any EP lab usage. Clinical trial registration NCT01360008 (first registration 25/05/2011).

AB - BACKGROUND: Pulmonary vein isolation (PVI) is recommended to treat paroxysmal and persistent atrial fibrillation (AF). This analysis aimed to assess the hospital efficiency of single-shot cryoballoon ablation (CBA) and point-by-point radiofrequency ablation (RFA).METHODS: The discrete event simulation used PVI procedure times from the FREEZE Cohort study to establish the electrophysiology (EP) lab occupancy time. 1000 EP lab days were simulated according to an illustrative German hospital, including 3 PVI cases per day using CBA at one site and RFA at the other.RESULTS: The analysis included 1560 CBA patients and 1344 RFA patients from the FREEZE Cohort. Some baseline patients' characteristics were different between groups (age, AF type, and some concomitant diseases), without being statistically associated to ablation procedure time. Mean procedure time was 122.2 ± 39.4 min for CBA and 160.3 ± 53.5 min for RFA (p < 0.0001). RFA was associated with a more than five-fold increase of cumulative overtime compared to CBA over the simulated period (1285 h with RFA and 253 h with CBA). 70.7% of RFA lab days included overtime versus 25.7% for CBA. CBA was associated with more days with an additional hour at the end of the EP lab shift compared to RFA (47.8% vs 11.5% days with one hour left, respectively).CONCLUSION: CBA is faster and more predictable than point-by-point RFA, and enables improvements in EP lab efficiency, including: fewer cumulative overtime hours, more days where overtime is avoided and more days with remaining time for the staff or for any EP lab usage. Clinical trial registration NCT01360008 (first registration 25/05/2011).

KW - Humans

KW - Cohort Studies

KW - Cryosurgery/adverse effects

KW - Atrial Fibrillation/diagnosis

KW - Catheter Ablation/adverse effects

KW - Pulmonary Veins/surgery

KW - Electrophysiology

KW - Treatment Outcome

KW - Recurrence

U2 - 10.1186/s12872-022-03015-8

DO - 10.1186/s12872-022-03015-8

M3 - SCORING: Journal article

C2 - 36624380

VL - 23

SP - 8

JO - BMC CARDIOVASC DISOR

JF - BMC CARDIOVASC DISOR

SN - 1471-2261

IS - 1

ER -